– USA, CA – SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Angela Steinway to its Board as an Independent Director, effective December 14, 2021, bringing the board to nine directors, eight of whom are independent.
“Angela’s addition complements our Board’s existing skills and experiences. We are excited about the new perspective she will bring,” said Board Chair, Kirt Stephenson.
CEO Keith Valentine added, “We are pleased to welcome Angela to SeaSpine’s Board of Directors. Angela’s passion for life science technologies, combined with her experience in identifying and pursuing strategic opportunities, will provide us with a unique insight as we move through our next stages of growth. We look forward to working with Angela in meeting our corporate strategic goals.”
Ms. Steinway will also join the Audit Committee.
About Angela Steinway
Angela Steinway brings over 15 years of experience in the medical device industry, having worked in various strategy, sales, and finance functions throughout her career. Currently, she is the VP, Strategy, Business Development, and Private Label at Integra Lifesciences Holdings Corporation where she oversees strategy and business development for tissue technologies and regenerative medicine and has responsibility for approximately $120 million business serving non-core commercial markets. Ms. Steinway joined Integra in 2009 and, before her current role, held roles of increasing responsibility within the company’s finance and sales organizations. Earlier in her career, Ms. Steinway worked at Oppenheimer & Co (formerly CIBC World Markets) as a Securities Analyst, Medical Devices & Diagnostics Equity Research where her research focused on the medical technology industry.
Ms. Steinway earned her B.A. in Economics from the University of Pennsylvania and holds an Executive Education Certificate from the Wharton School of the University of Pennsylvania. She currently sits on the board of ProduceGood, an organization dedicated to finding sustainable solutions to alleviate hunger, reclaim and repurpose waste and promote community health.
About SeaSpine
SeaSpine is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions, as well as a market-leading surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic, and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery, and complex spinal deformity procedures. Expertise in orthobiologic sciences, as well as spinal implants, software, and advanced optics product development, allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and approximately 30 countries worldwide through a committed network of increasingly exclusive distribution partners.
For more information: https://www.seaspine.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.